<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T04:55:36Z</responseDate>
  <request identifier="oai:figshare.com:article/33920029" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33920029</identifier>
        <datestamp>2026-09-18T04:37:18Z</datestamp>
        <setSpec>category_388</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 5_USP26-mediated stabilization of RAD51 promotes endometrial cancer progression and limits ferroptosis.xlsx</dc:title>
          <dc:creator>Jiayu Jing (9131035)</dc:creator>
          <dc:creator>Qi Xie (230608)</dc:creator>
          <dc:creator>Shuang Jing (6009062)</dc:creator>
          <dc:creator>Na Li (6550)</dc:creator>
          <dc:creator>Yangyang Wang (642852)</dc:creator>
          <dc:creator>Yunfeng Zhang (87124)</dc:creator>
          <dc:creator>Yue Wang (65477)</dc:creator>
          <dc:subject>Oncology and Carcinogenesis not elsewhere classified</dc:subject>
          <dc:subject>deubiquitination</dc:subject>
          <dc:subject>endometrial cancer</dc:subject>
          <dc:subject>ferroptosis</dc:subject>
          <dc:subject>RAD51</dc:subject>
          <dc:subject>tumor progression</dc:subject>
          <dc:subject>ubiquitination</dc:subject>
          <dc:subject>USP26</dc:subject>
          <dc:description>Background&lt;p&gt;Ferroptosis is increasingly implicated in endometrial cancer, but the role of the homologous recombination protein RAD51 in ferroptotic stress and its post-translational regulation remain unclear.&lt;/p&gt;Methods&lt;p&gt;RAD51 expression was assessed in GEO datasets, UCEC tissues, and endometrial cancer cell lines. RAD51 loss-of-function was evaluated using proliferation, cell-death, Transwell, ferroptosis-related, and xenograft assays. IP–MS, co-immunoprecipitation, cycloheximide chase, proteasome inhibition, ubiquitination assays, USP26-C304S, and RAD51 rescue experiments were used to define USP26-dependent RAD51 regulation.&lt;/p&gt;Results&lt;p&gt;RAD51 was upregulated in endometrial cancer and its depletion reduced proliferation and xenograft growth, lowered Transwell migration/invasion readouts, and increased ferroptosis-associated changes. USP26 associated with RAD51, reduced its ubiquitination, and stabilized RAD51 in a catalytic activity-dependent manner. RAD51 re-expression partially rescued the effects of USP26 depletion.&lt;/p&gt;Conclusions&lt;p&gt;The USP26–RAD51 axis supports endometrial cancer progression and limits ferroptosis-associated stress, identifying RAD51 protein stability as a potential mechanistic vulnerability.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T04:37:18Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fonc.2026.1896160.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_5_USP26-mediated_stabilization_of_RAD51_promotes_endometrial_cancer_progression_and_limits_ferroptosis_xlsx/33920029</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
